|
May 15
|
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
|
|
May 10
|
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
|
|
May 9
|
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
|
|
May 9
|
Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
|
|
May 8
|
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
|
|
May 7
|
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
|
|
May 7
|
UPDATE 3-Future Pak sweetens take-private offer for Vanda Pharmaceuticals
|
|
Apr 30
|
Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
|
|
Apr 25
|
UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
|
|
Apr 25
|
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
|
|
Apr 24
|
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
|
|
Apr 24
|
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
|
|
Apr 22
|
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
|
|
Apr 22
|
UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
|
|
Apr 22
|
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
|
|
Apr 19
|
Butler Hall Capital urges Vanda to engage in sales discussions
|
|
Apr 18
|
Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up
|
|
Apr 18
|
Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
|
|
Apr 17
|
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
|